Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Hao Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Xinqiao Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Reactive Oxygen Species, Osteoporosis, Caffeic Acids. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Clinical Research Project of the Second Affiliated Hospital of Army Medical University, the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission.
Abstract (Originalsprache)
Osteoporosis, characterized by osteoclastic bone resorption, has been the focus of research. Studies implicate that reactive oxygen species (ROS) accumulate intracellularly during osteoclastogenesis. Salvianolic acid A (SAA), a compound derived from Salvia miltiorrhiza , has been widely used to treat cardiovascular and cerebrovascular disorders, owing to its antioxidant and anti‐inflammatory properties. In this study, we investigated the therapeutic effects of SAA on osteoporotic bone loss in vitro and in osteoporotic mice induced by ovariectomy (OVX) and explored the underpinning mechanisms. In vitro, SAA significantly restrained osteoclastogenesis and osteoclastic resorption in a dose‐ and time‐dependent manner. SAA markedly blocked the expression of osteoclast‐specific genes and proteins such as NFATc1 and c‐Fos. Specifically, SAA reduced ROS production by enhancing the expression and nuclear translocation of nuclear factor erythroid 2‐related factor 2 (Nrf2) to activate HO‐1 and catalase, with no effect on Bach1. In addition, SAA simultaneously suppressed the NF‐κB and mitogen‐activated protein kinase (MAPK) signaling pathway, ultimately arresting NFATc1 expression to constrain the differentiation and function of osteoclasts. Micro‐CT and histological evidence demonstrated that SAA at a nontoxic dose successfully reduced bone loss induced by OVX, with fewer mature osteoclasts. These findings revealed that SAA provides a potential treatment strategy for reducing osteoclast‐related bone ailments, including osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Xinqiao Hospital, Army Medical University, Chongqing, China.
ORCID-Profile: Hao Qiu
Förderung
- the Clinical Research Project of the Second Affiliated Hospital of Army Medical University
- the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission
Zitieren
APA
Qiu, H., Cai, C., Zhang, Y., Yang, S., Hu, X., & Chu, T. (2025). Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8503
Vancouver
Qiu H, Cai C, Zhang Y, Yang S, Hu X, Chu T. Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway. Phytotherapy Research. 2025. doi:10.1002/ptr.8503
BibTeX
@article{Qiu2025,
author = {Qiu, Hao and Cai, Chenhui and Zhang, Ying and Yang, Sizhen and Hu, Xu and Chu, Tongwei},
title = {Salvianolic Acid A Mitigates Osteoporotic Bone Loss by Repressing Reactive Oxygen Species via the Nrf2–HO‐1 Pathway},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8503}
}
EUVIMED